We are live on ! Find out more
CCRN

Cross Country Healthcare
CCRN

Delisted

CCRN was delisted on the 20th of July, 2026.

169 hedge funds and large institutions have $450M invested in Cross Country Healthcare in 2025 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 48 increasing their positions, 67 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 27

31% more call options, than puts

Call options by funds: $2.29M | Put options by funds: $1.75M

10% more capital invested

Capital invested by funds: $411M → $450M (+$39.2M)

5% more funds holding

Funds holding: 161169 (+8)

0.62% more ownership

Funds ownership: 96.1%96.72% (+0.62%)

28% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 67

Holders
169
Holders Change
+8
Holders Change %
+4.97%
% of All Funds
2.22%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
36
Increased
48
Reduced
67
Closed
27
Calls
$2.29M
Puts
$1.75M
Net Calls
+$542K
Net Calls Change
+$338K
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$4.19M +$1.17M +88,407 +43%
WAM
27
Weiss Asset Management
Massachusetts
$3.94M -$504K -38,136 -12%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$3.44M -$73.3K -5,551 -2%
GCIA
29
Gabelli & Co Investment Advisers
New York
$3.36M -$2.35M -178,300 -43%
Renaissance Technologies
30
Renaissance Technologies
New York
$2.88M -$1.14M -85,983 -30%
SGCM
31
Sand Grove Capital Management
United Kingdom
$2.73M -$1.72M -129,941 -40%
Adage Capital Partners
32
Adage Capital Partners
Massachusetts
$2.63M +$2.45M +185,330 New
CL
33
CSS LLC
Illinois
$2.49M -$403K -30,501 -15%
KIM
34
Kestrel Investment Management
California
$2.48M
CAU
35
Caxton Associates (UK)
$2.46M -$423K -31,998 -16%
Jane Street
36
Jane Street
New York
$2.43M +$1.84M +139,564 +443%
MCM
37
Moore Capital Management
New York
$2.37M +$817K +61,894 +59%
WP
38
Woodline Partners
California
$2.2M +$2.04M +154,761 New
SEI Investments
39
SEI Investments
Pennsylvania
$2M -$77.9K -5,901 -4%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$1.74M -$33.3K -2,520 -2%
UBS Group
41
UBS Group
Switzerland
$1.63M -$953K -72,135 -39%
PCM
42
Prelude Capital Management
New York
$1.62M +$294K +22,252 +24%
Skandinaviska Enskilda Banken (SEB)
43
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.6M -$688K -52,069 -32%
BCM
44
BCK Capital Management
Connecticut
$1.59M +$695K +52,658 +89%
YCM
45
Yakira Capital Management
Connecticut
$1.57M +$56.1K +4,250 +4%
CC
46
Carlson Capital
Texas
$1.55M +$124K +9,389 +9%
PCMI
47
Paradigm Capital Management Inc
New York
$1.53M
GLF
48
Groupe la Francaise
France
$1.48M -$1.09M -82,254 -44%
Invesco
49
Invesco
Georgia
$1.38M -$93.4K -7,075 -7%
Squarepoint
50
Squarepoint
New York
$1.21M +$660K +49,942 +141%

CCRN Hedge Fund Activity: Q3 2025 in Review

169 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Cross Country Healthcare (CCRN) for Q3 2025, worth a combined $450M — up 9.5% from $411M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new CCRN positions and 27 closed out — a net gain of 9 holders — while 48 added to existing stakes and 67 trimmed.

The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $11.1M. The largest seller was AllianceBernstein, cutting an estimated $6.7M.

  • 169 institutional investors held Cross Country Healthcare (CCRN) as of Q3 2025, up from 161 in Q2 2025.
  • Funds reported $450M of Cross Country Healthcare stock for Q3 2025, up 9.5% quarter-over-quarter.
  • 36 funds opened new Cross Country Healthcare positions in Q3 2025 and 27 closed out, a net change of +9 holders.
  • The largest Cross Country Healthcare buyer in Q3 2025 was TIG Advisors LLC, an estimated $11.1M added.
  • The largest Cross Country Healthcare seller in Q3 2025 was AllianceBernstein, an estimated $6.7M sold.

Based on aggregated 13F filings for Q3 2025.